artenimol has been researched along with deferoxamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, H; Ji, P; Qiao, C; Yan, X; Yu, Y | 1 |
| Huang, XJ; Lu, YB; Ma, ZQ; Wei, EQ; Zhang, WP | 1 |
| Chan, HW; Lai, HC; Singh, NP | 1 |
3 other study(ies) available for artenimol and deferoxamine
| Article | Year |
|---|---|
Antitumor activity of endoperoxide-iron chelator conjugates-design, synthesis and biological evaluation.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Iron Chelating Agents; Molecular Structure; Peroxides; Structure-Activity Relationship | 2015 |
Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Chelating Agents; Deferoxamine; Ferrous Compounds; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Rats; Reactive Oxygen Species; Sesquiterpenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factors | 2007 |
Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine.
Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cyclic N-Oxides; Deferoxamine; Drug Antagonism; Drug Screening Assays, Antitumor; Free Radical Scavengers; Free Radicals; Humans; Siderophores | 2013 |